Artesunate Injection is a potent antimalarial medication primarily used for the treatment of severe malaria caused by Plasmodium falciparum. This injectable drug provides rapid action against the malaria parasite, ensuring effective reduction of parasite load in critically ill patients. Artesunate is highly recommended by healthcare professionals for parenteral treatment, particularly in cases where oral administration is not feasible due to patient condition or severity of infection. It is formulated for intravenous or intramuscular injection, enabling swift absorption and fast therapeutic effects essential for life-threatening malaria management. The product is suitable for hospitals, clinics, and specialized malaria treatment centers, facilitating improved patient outcomes in malaria-endemic regions. Artesunate Injection meets stringent quality controls and is manufactured following standard pharmaceutical guidelines to ensure potency, purity, and safety. Ideal for B2B pharmaceutical suppliers and healthcare institutions seeking reliable antimalarial injectable solutions for malaria treatment protocols.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Artesunate |
| Usage | Treatment of severe malaria |
| Administration Route | Intravenous or intramuscular injection |
| Rapid Action | Provides fast parasite clearance |
| Formulation | Sterile injectable solution |
| Indication | Severe Plasmodium falciparum malaria |
| Packaging | Available in vials for injection |
| Recommended For | Hospitals, clinics, and malaria treatment centers |
| Regulatory Compliance | Complies with pharmaceutical quality standards |
| Attributes | Description |
|---|---|
| Dosage Strength | Typically 60 mg or 120 mg per vial |
| Form | Injection |
| Shelf Life | 2-3 years from manufacturing date |
| Storage Conditions | Store in a cool, dry place away from light |
| Packaging Type | Glass vial with sterile solution |
| Pharmacological Classification | Antimalarial agent |
| Manufacturer Compliance | GMP certified manufacturing facility |
| Intended Use | Hospital/clinical use for severe malaria treatment |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Artesunate Injection is specifically recommended for the treatment of severe malaria caused by Plasmodium falciparum and is not intended for uncomplicated or non-falciparum malaria forms.
The injection can be administered intravenously or intramuscularly depending on clinical judgment and patient condition.
Due to the severity of cases treated with Artesunate Injection and need for close monitoring, it is primarily intended for hospital or clinical settings.
Yes, it should be stored in a cool, dry place away from light to maintain its stability and effectiveness.
Manufacturers comply with Good Manufacturing Practices (GMP) and pharmaceutical regulatory standards to ensure product safety and efficacy.
Artesunate use in the tratment of malaria.
